טוען...
Dose modification and dose intensity during treatment with pirfenidone: analysis of pooled data from three multinational phase III trials
INTRODUCTION: Temporary dose modifications, such as reductions or interruptions, may allow patients to better manage adverse events (AEs) associated with pirfenidone use and continue treatment for idiopathic pulmonary fibrosis (IPF). However, the impact of such dosing adjustments on efficacy and saf...
שמור ב:
| הוצא לאור ב: | BMJ Open Respir Res |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Publishing Group
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6089326/ https://ncbi.nlm.nih.gov/pubmed/30116539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjresp-2018-000323 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|